Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RESPIRODYNE PULMONARY FUNCTION TEST

K-Number: K834475 · 1984-02-17

ApplicantChesebrough-Pond'S U.S.A. Co.
Decision Date1984-02-17
Product CodeBZG
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

RESPIRODYNE PULMONARY FUNCTION TEST is the device name listed in this FDA 510(k) record. The listed applicant is Chesebrough-Pond'S U.S.A. Co.. It received FDA 510(k) clearance on 1984-02-17 under 510(k) number K834475. The device is classified under product code BZG. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RESPIRODYNE PULMONARY FUNCTION TEST?

RESPIRODYNE PULMONARY FUNCTION TEST is a medical device that received FDA 510(k) clearance on 1984-02-17. The listed applicant is Chesebrough-Pond'S U.S.A. Co.. The 510(k) number is K834475.

When did RESPIRODYNE PULMONARY FUNCTION TEST receive FDA 510(k) clearance?

RESPIRODYNE PULMONARY FUNCTION TEST received FDA 510(k) clearance on 1984-02-17, under 510(k) number K834475.

Who is the listed applicant for RESPIRODYNE PULMONARY FUNCTION TEST?

The FDA 510(k) record lists Chesebrough-Pond'S U.S.A. Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RESPIRODYNE PULMONARY FUNCTION TEST?

The FDA product code for RESPIRODYNE PULMONARY FUNCTION TEST is BZG.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Chesebrough-Pond'S U.S.A. Co. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K863866RESPIRADYNE II(TM)K862803CHESEBROUGH POND'S HYDROCOLLOID DRESSINGK851382CHESEBROUGH-POND'S SEQUENTIAL WOUND DRESSINGK851383BLISTERFILM TRANSPARENT DRESSINGK851539CHESEBROUGH-PONDS KANGAROO PUMP SET W/EASY-CAP CLOK843567KANGAROO NASOGASTRIC FEEDING TUBE

View all 33 devices →

Related Devices (Code: BZG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K251777MESI mTABLET SPIROMesi D.O.O.K241843TD-7301 Spirometer (TD-7301)Gostar Co., Ltd.K231416Air Next (NVD-02)Nuvoair ABK230501Spirobank OxiMir Medical International Research USAK230178EasyOne Sky SpirometerNdd Medizintechnik AGK222525Alveoair Digital SpirometerRoundworks Technologies Private Limited

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑